Skip to content

Health After Birth Intervention Trial

A Feasibility RCT Investigating the Effect of a Kilocalorie Controlled, Low Carbohydrate Dietary Intervention, Behavioural Modification and Telehealth vs a Standard 1:1 NHS Weight Management Programme in Post-partum Women Living With Obesity

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05137691
Acronym
HABIT
Enrollment
3
Registered
2021-11-30
Start date
2022-05-19
Completion date
2022-09-15
Last updated
2022-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

weight management postpartum

Brief summary

This trial is to assess the feasibility of a larger, definitive RCT and determine the clinical effectiveness of an NHS 1:1 programme versus a modified programme with a low carbohydrate dietary intervention (as per Feinman and colleagues classification) with telehealth, physical activity and enhanced behaviour change on specified health outcomes amongst post-partum women living with obesity

Detailed description

For individuals living with obesity, the post-partum period is currently the initial, optimal timeframe for weight management. Many women reconceive during the post-partum phase, increasing the risk of between-pregnancy bodyweight retention and even gain. Consequentially, many re-enter subsequent pregnancies with a higher BMI often associated with unfavourable obstetric outcome and further cyclical perpetuation. Health behaviour change is an important facet within weight management interventions and delivery may be enhanced by digital technologies, for example, telehealth. Short messaging service (SMS) may be used to enhance communication between patients and practitioner and is relatively inexpensive to use. Low carbohydrate diets continue to gain traction however research is arguably confounded by the lack of a universally agreed definition and classification. Feinman and colleagues (2015) propose intermediary categories. The experimental arm of this trial will be encouraged to adopt a non-ketogenic LCD as per Feinman.

Interventions

OTHERAdapted NHS weight management 1:1 programme

Adapted NHS 1:1 weight management programme with a low carbohydrate dietary focus, incorporating enhanced behaviour change via telehealth, step count and pedometer

OTHERNHS 1:1 weight management programme

NHS 1:1 weight management programme

Sponsors

NHS Lothian
CollaboratorOTHER_GOV
Queen Margaret University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Feasibility Randomised Controlled Trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult aged 18 or above * Ready and motivated to make lifestyle changes * Have a Body Mass Index of ≥30 kg/m2 (at initial booking appointment) Additional study specific criteria * English speaking and ability to read English language * Capacity to consent to participating in the study * Are non-diabetic or those with Type 2 diabetes which is diet controlled * Deemed medically fit by GP/medical professional to participate via email * Have recently given birth (within 1 year) * Are not receiving weight management support elsewhere e.g. NHS, Scottish slimmers, weight watchers * Have access to a mobile phone and weighing scales

Exclusion criteria

* Have uncontrolled hypothyroidism * Have unstable psychosis or severe and unstable personality disorder * Are pregnant * Have dementia * Have moderate to severe learning disability or learning difficulty which impairs the ability to adhere to the programme (identified by medical history and confirmed with GP) * Current alcohol or substance misuse (6 month period of abstinence) * Active purging * Bulimia Nervosa * Binge Eating Disorder Additional study specific criteria * Known cancers * Type 1 Diabetes or Type 2 Diabetes on any Diabetic medication (including Insulin) * Have a pacemaker * Renal impairment * Taking Orlistat or any other weight loss medication or had previous bariatric surgery

Design outcomes

Primary

MeasureTime frameDescription
Change in Bodyweight (Kilograms)Proposed 0,3,6,8 monthsBodyweight measured by the CI or self-reported

Secondary

MeasureTime frameDescription
Change in Waist circumference (Centimetres)Proposed 0,3,6,8 monthsSECA Ergonomic measuring tape
Change in systolic and diastolic Blood pressureProposed 0,3,6,8 monthsStandard technique
Change in Physical activity levelsProposed 0,3,6,8 monthsLevel of physical activity (minutes) and step count from pedometer data
Change in emotional eating using the Weight loss Readiness Test II0,3,6,8 monthsIncidence of emotional eating (if present) determined by change score. Increased score is less favourable
Change in Body composition (Fat mass/fat free mass)Proposed 0,3,6,8 monthsMedical grade
Change in psychological distress (if present) using the Clinical Outcomes in Routine Evaluation-10 screening toolBaseline, post-intervention at 3 monthsMeasured using the Clinical Outcomes in Routine Evaluation-10 tool using change scores. An increased score is less favourable
Change in Quality of lifeProposed 0,3,6,8 monthsMeasured using the World Health Organisation Quality of life (BREF) tool. A lower score is less favourable
Food frequency questionnaireBaselineStandard validated tool
Diet qualityProposed 0,3,6,8 monthsDiet quality measured using a 3 day unweighed food diary
Change in hunger and eating cues using the Weight loss Readiness Test II0,3,6,8 monthsHunger and eating cues determined by change score. Increased score is less favourable

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026